Related Experiment Video
Updated: May 1, 2026

12:48
PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
Published on: December 27, 2013
67.2K
Novel pH-sensitive biodegradable polymeric drug delivery systems based on ketal polymers
Journal of Nanoscience and Nanotechnology
|April 16, 2014
Summary
Novel pH-sensitive ketal-based polymers offer biodegradable drug delivery, degrading into safe byproducts. These advanced materials avoid inflammation, paving the way for new therapeutic applications.
Area of Science:
- Polymer Chemistry
- Biomaterials Science
- Drug Delivery Systems
Background:
- pH-sensitive drug delivery systems are crucial for targeted therapies.
- Ketal derivatives offer a novel approach to creating pH-degradable polymers.
- Existing systems may face challenges like inflammatory responses.
Purpose of the Study:
- To review recent advancements in ketal-based biodegradable polymeric drug delivery systems.
- To highlight the pH-sensitive nature and degradation mechanisms of ketal polymers.
- To discuss the preparation, characterization, and applications of these novel materials.
Main Methods:
- Literature review of ketal-based polymers for drug delivery.
- Analysis of ketal polymer structure, synthesis, and characterization techniques.
- Exploration of applications in micro/nano drug carriers for various diseases.
Main Results:
- Ketal polymers degrade into neutral alcohols and ketones, minimizing inflammatory issues.
- These polymers exhibit pH-sensitive degradation, enabling controlled drug release.
- Ketal-based micro/nano carriers show promise for targeted therapeutic delivery.
Conclusions:
- Ketal-based polymers represent a promising class of materials for advanced drug delivery.
- Their pH-degradable nature and biocompatibility offer significant advantages over conventional systems.
- Further research into ketal polymers will likely expand their therapeutic potential.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Oral Drug Delivery Systems: Delayed-Release Systems
222
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
222
Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Modified-Release Drug Delivery Systems: Classification
315
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
315
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164

